4-amino-3-benzyl-4,5-dihydro-1H-1,2,4-triazole-5-thione, 95+%, 250mg

[(5-methyl-1,3,4-oxadiazol-2-yl)thio]acetic acid, 95.0%, 25g

2-Methyl-2-adamantanol, min. 98%, for synthesis, 5 g, glass packaging

Methyl 2-(2-bromo-3,6-difluorophenyl)acetate, 97%, 1g

4-Bromo-5-ethyl-1-methyl-1H-pyrazole-3-carboxylic acid, 95%, 100mg

Tetrathiafulvalene (purified by sublimation)>99.0%(GC)1g

5-formyl-2-hydroxybenzonitrile, 98.0%, 1g

1'-Benzyl-7-methoxyspiro[3H-chromene-2,4'-piperidine]-4-one, 98+%, 25g

2,2,2-TRIFLUORO-1-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ETHANOL, 95.0%, 250mg

1-Cyclopropyl-4-iodobenzene, 98%, 250mg

2-Piperidinecarboxamide, 97.0%, 10g

7-Methoxy-2,3-dihydro-1H-inden-1-amine, 95.0%, 100mg

6-BROMO-3-IODOQUINOLINE, 95.0%, 250mg